Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Inflammation-Schizophrenia: A Bidirectional Causal Association Mediated by Cytokines Publisher



Shamabadi A1, 2 ; Akhondzadeh S2
Authors

Source: Avicenna Journal of Medical Biotechnology Published:2023


Abstract

[No abstract available]
Related Docs
View other Related Docs
1. Efficacy and Safety of Adjunctive Therapy With Fingolimod in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Schizophrenia Research (2023)
2. Cytokine Alterations in Schizophrenia: An Updated Review, Frontiers in Psychiatry (2019)
3. Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial, International Journal of Neuropsychopharmacology (2020)
Experts (# of related papers)
View all Related Experts
Shahin Akhondzadeh Basti (7)
Farzin Rezaei (2)
Other Related Docs
4. Adjuvant Palmitoylethanolamide Therapy With Risperidone Improves Negative Symptoms in Patients With Schizophrenia: A Randomized, Double-Blinded, Placebo-Controlled Trial, Psychiatry Research (2022)
5. Interdisciplinary Collaboration Between Bench and Bedside in the Covid-19 Pandemic, Avicenna Journal of Medical Biotechnology (2023)
6. Toward Personalized Psychiatry: Integrating Pharmacogenetics Into Psychiatry, Journal of Iranian Medical Council (2023)
7. Cilostazol Adjunctive Therapy in Treatment of Negative Symptoms in Chronic Schizophrenia: Randomized, Double-Blind, Placebo-Controlled Study, Human Psychopharmacology (2017)
8. Integrating Psychiatry and Medical Biotechnology As a Way to Achieve Scientific, Precision, and Personalized Psychiatry, Avicenna Journal of Medical Biotechnology (2021)